A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.

chronic thromboembolic pulmonary hypertension echocardiographic probability of pulmonary hypertension echocardiography pulmonary embolism

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
18 Feb 2022
Historique:
received: 17 01 2022
revised: 09 02 2022
accepted: 13 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

We hypothesized that a Doppler index, the ratio of tricuspid regurgitation peak gradient (TRPG) to pulmonary ejection acceleration time (AcT), improves the assessment of the echocardiographic probability of pulmonary hypertension in the identification of CTEPH and chronic thromboembolic pulmonary disease (CTED) in symptomatic patients after PE. Doppler echocardiography is recommended as the initial imaging tool for the diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) after acute pulmonary embolism (PE). We analyzed the data from 845 consecutive PE (468 women; 61 ± 18 years) survivors who completed at least 6 months of anticoagulation therapy. Here, 555 patients (325 women; 66 ± 16 years) reporting functional impairment (FI) underwent transthoracic echocardiography. We included 506 patients (297 women; age 63.4 ± 16.6 years) in whom both AcT and TRPG were available into the current study. The presence of a minimum of intermediate echocardiographic probability of PH necessitated the diagnosis of CTEPH. Echocardiography revealed a high echocardiographic probability of PH in 69 (13.6%) and intermediate echocardiographic probability in 109 (21.5%) patients. CTEPH was diagnosed in 35 (6.9%) patients and CTED in 22 (4.3%) patients. TRPG/AcT was significantly higher in the combined CTEPH + CTED group than in those with other causes of FI (0.412 (0.100-2.197) vs. 0.208 (0.026-0.115), A Doppler index TRPG/AcT improves the assessment of symptomatic PE survivors. TRPG/AcT > 0.6 indicates a high probability of CTEPH or CTED, whereas TRPG/AcT < 0.6 allows for the safe exclusion of CTEPH + CTED in patients with a low echocardiographic probability of PH.

Sections du résumé

BACKGROUND BACKGROUND
We hypothesized that a Doppler index, the ratio of tricuspid regurgitation peak gradient (TRPG) to pulmonary ejection acceleration time (AcT), improves the assessment of the echocardiographic probability of pulmonary hypertension in the identification of CTEPH and chronic thromboembolic pulmonary disease (CTED) in symptomatic patients after PE. Doppler echocardiography is recommended as the initial imaging tool for the diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) after acute pulmonary embolism (PE).
METHODS METHODS
We analyzed the data from 845 consecutive PE (468 women; 61 ± 18 years) survivors who completed at least 6 months of anticoagulation therapy. Here, 555 patients (325 women; 66 ± 16 years) reporting functional impairment (FI) underwent transthoracic echocardiography. We included 506 patients (297 women; age 63.4 ± 16.6 years) in whom both AcT and TRPG were available into the current study. The presence of a minimum of intermediate echocardiographic probability of PH necessitated the diagnosis of CTEPH.
RESULTS RESULTS
Echocardiography revealed a high echocardiographic probability of PH in 69 (13.6%) and intermediate echocardiographic probability in 109 (21.5%) patients. CTEPH was diagnosed in 35 (6.9%) patients and CTED in 22 (4.3%) patients. TRPG/AcT was significantly higher in the combined CTEPH + CTED group than in those with other causes of FI (0.412 (0.100-2.197) vs. 0.208 (0.026-0.115),
CONCLUSIONS CONCLUSIONS
A Doppler index TRPG/AcT improves the assessment of symptomatic PE survivors. TRPG/AcT > 0.6 indicates a high probability of CTEPH or CTED, whereas TRPG/AcT < 0.6 allows for the safe exclusion of CTEPH + CTED in patients with a low echocardiographic probability of PH.

Identifiants

pubmed: 35207345
pii: jcm11041072
doi: 10.3390/jcm11041072
pmc: PMC8879629
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
J Am Soc Echocardiogr. 2019 Jul;32(7):807-810
pubmed: 31272591
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Blood Rev. 2014 Nov;28(6):221-6
pubmed: 25168205
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1301-1310
pubmed: 29045589
Thromb Res. 2020 Feb;186:30-35
pubmed: 31862573
Eur Respir J. 2021 Jun 17;57(6):
pubmed: 33334946
Heart. 2011 Apr;97(8):612-22
pubmed: 21357375
Eur Respir J. 2020 Jun 25;55(6):
pubmed: 32184319
J Am Soc Echocardiogr. 2016 Sep;29(9):907-13
pubmed: 27427291
Eur Respir J. 2017 Feb 23;49(2):
pubmed: 28232411
J Am Soc Echocardiogr. 2015 Jan;28(1):108-15
pubmed: 25441329
J Am Heart Assoc. 2018 Jun 30;7(13):
pubmed: 29960993
Hamostaseologie. 2018 Feb;38(1):22-32
pubmed: 29536477
Am Fam Physician. 2016 Sep 15;94(6):463-9
pubmed: 27637122
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
Circulation. 2014 Oct 28;130(18):1636-61
pubmed: 25246013
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
J Thromb Haemost. 2018 Nov;16(11):2168-2174
pubmed: 30099844
Eur Respir J. 2018 Apr 4;51(4):
pubmed: 29563171
Eur Respir J. 2018 Dec 6;52(6):
pubmed: 30409820
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Card Fail. 2017 Jan;23(1):29-35
pubmed: 27742455
J Am Soc Echocardiogr. 2021 Jun;34(6):690-692.e1
pubmed: 33383123
Eur Respir J. 2013 Feb;41(2):462-8
pubmed: 22700839
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161

Auteurs

Olga Dzikowska-Diduch (O)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Katarzyna Kurnicka (K)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Barbara Lichodziejewska (B)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Olga Zdończyk (O)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Dominika Dąbrowska (D)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Marek Roik (M)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Szymon Pacho (S)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Maksymilian Bielecki (M)

Department of Psychology, SWPS University of Social Sciences and Humanities, 03-815 Warsaw, Poland.

Piotr Pruszczyk (P)

Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Classifications MeSH